An international research team with strong participation from DTU has developed a new biotechnological platform that makes it ...

Most cells in the human body exist in complex three-dimensional environments, yet they are still commonly studied on flat plastic dishes. These two-dimensional cultures distort cell behavior, limiting ...

Renier Brentjens, MD, PhD, one of the pioneers in the development of chimeric antigen receptor (CAR) T-cell therapy, is poised to see the technology take its next big leap, with researchers testing ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

Alejandro Weinstein, Chairman of Pluri, shares insights on the future of biotechnology and cell-based therapies. Weinstein ...

Millions of people worldwide suffer from gum disease, yet we still don't fully understand how healthy gums turn into damaged, ...

GROTON, Conn.--(BUSINESS WIRE)--Nimbus Power Systems, Inc., a pioneering developer of advanced fuel cell technologies for heavy-duty vehicles, today announced the successful completion of a fuel cell ...

Cellares is partnering with Stanford Medicine to automate gene-edited stem cell therapy for HIV and more than 19 rare diseases.

Thanks to a new technology called Moscot ("Multi-Omics Single-Cell Optimal Transport"), researchers can now observe millions of cells simultaneously as they develop into a new organ—for example, a ...

Stellantis has decided to discontinue its hydrogen fuel cell technology development program due to the lack of mid-term prospects for the hydrogen market, impacted by limited refueling infrastructure ...